Fortis Healthcare shares outlook by Nomura: Rating neutral and target price remains ₹1030 - check rationale

As reported by mint - markets

Fortis Healthcare’s share price has remained under pressure in the near term, declining 4.61% over the past week and 6.04% over the last month

▸ MARKET SAMACHAR VIEW

NEUTRAL

Read full article on mint - markets ↗

Market Samachar is a news aggregator. This article was originally published by mint - markets. Tap the button above to read the full story on their site.

INDIAN Rupee languishes at six-week low ahead of Fed outcome, RBI limits losses Markets-Economic Times
INDIAN NSE IPO: Every Rs 10 move in shares could swing Radhakishan Damani’s wealth by nearly Rs 40 crore Markets-Economic Times
COMPANIES Sensex rises 333 points, Nifty closes above 23,200; all eyes on Fed meet outcome. What to expect? Stocks-Markets-Economic Times
INDIAN Penny stock under 10 rupees hits 5% upper circuit after this acquisition update mint - markets
INDIAN ₹65 dividend per share: Bajaj Holdings announces cash reward; check record date, stock performance, payment date mint - markets
INDIAN Borosil Renewables' entry into the solar rooftop sector a significant positive, shares may see an upswing, say experts mint - markets
INDIAN NSE IPO GMP slips ahead of launch tomorrow, 17 September: Should you subscribe at IPO price of ₹1,785? mint - markets
GLOBAL A backlash over data centres is another threat to the AI juggernaut BBC News

Fortis Healthcare shares outlook by Nomura: Rating neutral and target price remains ₹1030 - check rationale

More from Market Samachar